Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eni Andersson

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Scientific Reports|March 5, 2021
Antibodies to SARS-CoV-2 and risk of past or future sick leaveJoakim Dillner, K Miriam Elfström, Jonas Blomqvist, et al.
Nature Communications|October 9, 2020
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in SwedenAnn-Sofie Rudberg, Sebastian Havervall, Anna Månberg, et al.
Plos One|January 12, 2022
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infectionSebastian Havervall, August Jernbom Falk, Jonas Klingström, et al.
The Journal of Infectious Diseases|February 13, 2021
High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care WorkersJoakim Dillner, K Miriam Elfström, Jonas Blomqvist, et al.
Journal of Internal Medicine|August 30, 2021
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19Sebastian Havervall, Henry Ng, August Jernbom Falk, et al.
Clinical & Translational Immunology|July 23, 2021
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assaySophia Hober, Cecilia Hellström, Jennie Olofsson, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Scientific Reports|March 5, 2021
Antibodies to SARS-CoV-2 and risk of past or future sick leaveJoakim Dillner, K Miriam Elfström, Jonas Blomqvist, et al.
Nature Communications|October 9, 2020
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in SwedenAnn-Sofie Rudberg, Sebastian Havervall, Anna Månberg, et al.
Plos One|January 12, 2022
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infectionSebastian Havervall, August Jernbom Falk, Jonas Klingström, et al.
The Journal of Infectious Diseases|February 13, 2021
High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care WorkersJoakim Dillner, K Miriam Elfström, Jonas Blomqvist, et al.
Journal of Internal Medicine|August 30, 2021
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19Sebastian Havervall, Henry Ng, August Jernbom Falk, et al.
Clinical & Translational Immunology|July 23, 2021
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assaySophia Hober, Cecilia Hellström, Jennie Olofsson, et al.
Pageof 2